Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cardiovascular Device

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1556865

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1556865

Tissue Heart Valves

PUBLISHED:
PAGES: 174 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Description

Table of Contents

Global Tissue Heart Valves Market to Reach US$1.8 Billion by 2030

The global market for Tissue Heart Valves estimated at US$1.5 Billion in the year 2023, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 2.4% over the analysis period 2023-2030. Stented Valves, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Stentless Valves segment is estimated at 1.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$409.7 Million While China is Forecast to Grow at 4.9% CAGR

The Tissue Heart Valves market in the U.S. is estimated at US$409.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$354.0 Million by the year 2030 trailing a CAGR of 4.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Tissue Heart Valves Market - Key Trends and Drivers Summarized

How Are Tissue Heart Valves Enhancing Cardiac Surgery Outcomes?

Tissue heart valves, also known as bioprosthetic valves, are revolutionizing cardiac surgery by providing alternatives to mechanical valves with more natural hemodynamics and reduced requirements for anticoagulation therapy. These valves are typically made from animal tissues, such as porcine heart valves or bovine pericardium, which are treated to prevent rejection and ensure durability. Tissue valves are particularly advantageous for certain patient groups, including older adults, who may not tolerate the lifelong anticoagulation medication required with mechanical valves. The use of tissue valves can significantly improve quality of life by offering quieter operation and less rigid blood thinning regimes. Moreover, advancements in the design and fabrication of these valves have improved their durability and performance, making them suitable for a wider range of patients and increasingly preferred by surgeons for their physiological benefits and ease of implantation.

What Innovations Are Enhancing the Functionality of Tissue Heart Valves?

Innovations in tissue heart valves are focusing on extending durability, reducing the risk of complications, and enhancing patient compatibility. One significant advancement is the use of novel anticalcification treatments that extend the lifespan of tissue valves by preventing calcium deposits, a common cause of degeneration in bioprosthetic valves. Additionally, technologies such as computer-aided design and manufacturing are being employed to create valves that more closely mimic the natural anatomy of the patient’s heart, improving fit and function while reducing the risk of leakage or valve failure. Hybrid valves that combine tissue elements with synthetic materials are also being developed to offer the durability of mechanical valves while maintaining the physiological advantages of tissue valves. These technological advancements are not only expanding the applicability of tissue heart valves across different patient demographics but also improving the overall safety and outcomes of heart valve replacement surgeries.

How Do Tissue Heart Valves Impact Patient Recovery and Long-Term Health?

Tissue heart valves significantly impact patient recovery and long-term health by providing a more natural heart function and eliminating the need for intense lifelong anticoagulation therapy. Patients with tissue valves typically experience fewer restrictions on their lifestyle and diet compared to those with mechanical valves, as the risk of blood clot formation is lower. This reduction in the need for anticoagulation drugs decreases the risk of bleeding complications, which is particularly important for the elderly or those with lifestyle factors that increase bleeding risks. The more physiological flow dynamics associated with tissue valves also tend to result in better cardiac function over time, contributing to improved overall health and well-being. However, while tissue valves do not last as long as mechanical valves, the advances in valve treatment and technology continue to extend their lifespan, making them a viable option for an increasing number of patients.

What Trends Are Driving Growth in the Tissue Heart Valves Market?

The growth of the tissue heart valves market is driven by trends such as the aging global population, increasing incidences of heart valve diseases, and preferences for less invasive surgical interventions. As the population ages, the prevalence of conditions that require valve replacement, such as aortic stenosis, is rising. Tissue valves are particularly appealing in geriatric surgery due to their compatibility with the patient's natural physiology and reduced requirement for anticoagulation. Additionally, the increasing demand for minimally invasive procedures, such as transcatheter aortic valve replacement (TAVR), which uses tissue valves, is significantly influencing market growth. These procedures allow for quicker patient recovery and are often suitable for patients who are considered high-risk for open-heart surgery. Lastly, continuous improvements in bioprosthetic valve technologies, which enhance their appeal through longer service lives and better patient outcomes, are also key factors driving the expansion of the tissue heart valves market.

Select Competitors (Total 36 Featured) -

  • Abbott Cardiovascular
  • Arrotek Medical
  • Artivion, Inc
  • Beijing Balance Medical Technology Co.,Ltd.
  • Boston Scientific Corporation
  • Braile Biomedica
  • BridgeMed Solutions
  • Colibri Heart Valve LLC
  • Edwards Lifesciences Corporation
  • JC Medical, Inc.
Show more
Product Code: MCP24235

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tissue Heart Valves - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Preference for Bioprosthetic Over Mechanical Valves Drives Market Growth
    • Rising Global Incidence of Valve Diseases Bolsters Demand for Tissue Heart Valves
    • Minimally Invasive Valve Replacement Techniques Propel Use of Tissue Valves
    • Aging Population Demographics Increase Prevalence of Valve Replacement Surgeries
    • Patient-Specific Customization and 3D Printing Innovations in Valve Manufacturing
    • Global Expansion of Healthcare Infrastructure Improves Access to Valve Replacement Therapy
    • Insurance and Reimbursement Policies Impact Patient Access to Tissue Heart Valves
    • Advancements in Imaging and Diagnostic Techniques Improve Valve Disease Detection
    • Ongoing Research into Anticalcification Treatments to Extend Valve Life
    • Competition from Non-biological Valve Innovations Shapes Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Tissue Heart Valves Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Stented Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Stented Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Stented Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Stentless Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Stentless Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Stentless Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • JAPAN
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • CHINA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • EUROPE
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Tissue Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • FRANCE
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • GERMANY
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Tissue Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • INDIA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: India 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Tissue Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Tissue Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • AFRICA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!